In addition, ROS release also caused up-regulation of DR5 and co-treatment of DLBCL cells with Resveratrol and TRAIL significantly enhanced apoptosis in DLBCL. This evidence concerns the gene TNFRSF10B and diffuse large B-cell lymphoma.